NCT05573893

AUG 12, 2026 · OBSERVATIONAL STUDY

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

ClinicalTrials.gov

This is a prospective registry study under active recruitment with no results yet posted; it will generate real-world observational data on a marketed drug but cannot yet support clinical inference.